Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1240, pseudogene (RNU6-1240P) is a human genomic locus classified as a pseudogene, specifically deriving from U6 small nuclear RNA (snRNA)[1][5]. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; they arise from gene duplication or retrotransposition events and typically lack the ability to encode a functional product[2]. U6 snRNA pseudogenes, including RNU6-1240P, are distributed widely in mammalian genomes and predominantly result from LINE-1 (L1)-mediated retrotransposition, which is a process that copies RNA molecules back into DNA and inserts them at new genomic locations[2]. These U6 snRNA-derived pseudogenes do not produce functional RNAs or proteins and have no documented role as biological receptors, enzymes, or signaling molecules. They are not known therapeutic targets and have no established role in disease, biomarker development, or drug interaction[1][2][5]. RNU6-1240P is best described as a non-functional pseudogene copy of a small nuclear RNA gene, lacking recognized biological, clinical, or pharmacological relevance.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1240, pseudogene (RNU6-1240P).